p53 Status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9479-9490

  Goodrum, Felicia D ^a   Ornelles, David A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TEMPERATURE SENSITIVITY; VIRUS INFECTION; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0031798440     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9479-9490.1998     Document Type: Article

References (77)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. S. Struhl (ed.). 1993. Current protocols in molecular biology, vol. 2. Greene Publishing Associates and John Wiley and Sons, Inc., New York, N.Y.
2. Babich, A., L. T. Feldman, J. R. Nevins, J. E. Darnell, and C. Weinberger. 1983. Effect of adenovirus on metabolism of specific host mRNAs: transport control and specific translational discrimination. Mol. Cell. Biol. 3:1212-1221.
3. Babiss, L. E., H. S. Ginsberg, and J. E. Darnell. 1985. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol. Cell. Biol. 5:2552-2558.
4. Barker, D. D., and A. J. Berk. 1987. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 156:107-121.
5. Barlogie, B., M. N. Raber, J. Schumann, T. S. Johnson, B. Drewinko, D. F. Swatzendruber, W. Gohde, M. Andreeff, and E. J. Freireich. 1983. Flow cytometry in clinical cancer research. Cancer Res. 43:3982-3997.
6. Bernards, R., M. G. W. de Leeuw, A. Houweling, and A. J. van der Eb. 1986. Role of the adenovirus early region 1 B tumor antigens in transformation and lytic infection. Virology 150:126-139.
7. Bischoff, J. R., D. H. Kim, A. Williams, C. Heise, S. Horn, M. Muna, L. Ng, J. A. Nye, A. Sampson-Johannes, A. Fattaey, and F. McCormick. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376.
8. Bridge, E., and G. Ketner. 1990. Interaction of adenoviral E4 and E1B products in late gene expression. Virology 174:345-353.
9. Brower, M., D. N. Carney, H. K. Oie, A. F. Gazdar, and J. D. Minna. 1986. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 46:798-806.
10. Chiou, S.-K., C.-C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553-6566.
11. Crook, T., D. Wrede, and K. H. Vousden. 1991. p53 point mutations in HPV negative human cervical carcinoma cell lines. Oncogene 6:873-875.
12. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554.
13. Diller, L., J. Kassel, C. E. Nelson, M. A. Gryka, G. Litwak, M. Gehardt, B. Bressac, M. Ozturk, S. J. Baker, B. Vogelstein, and S. H. Friend. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772-5781.
14. Dobner, T., N. Horikoshi, S. Rubenwolf, and T. Shenk. 1996. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272:1470-1473.
15. El-Deiry, W. S., J. W. Harper, P. M. O'Conner, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and B. Vogelstein. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174.
16. El-Deiry, W. S., T. Tokino, V. E. Velculescu, and D. B. Levy, R. Parsons, J. M. Trent, K. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF-1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
17. Flint, J., and T. Shenk. 1997. Viral transactivating proteins. Annu. Rev. Genet. 31:177-212.
18. Fries, K. L., W. E. Miller, and N. Raab-Traub. 1996. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70:8653-8659.
19. Gallimore, P. H., P. A. Sharp, and J. Sambrook. 1974. Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA in nine lines of transformed rat cells using specific fragments of the viral genome. J. Mol. Biol. 89:49-72.
20. Goodrum, F. D., and D. A. Ornelles. 1997. The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle. J. Virol. 71:548-561.
21. Goodrum, F. D., and D. A. Ornelles. Unpublished results.
22. Goodrum, F. D., T. Shenk, and D. A. Ornelles. 1996. Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. J. Virol. 70:6323-6335.
23. Graham, F. L., P. J. Abrahams, C. Mulder, H. L. Heijneker, S. O. Warnaar, A. J. de Vries, W. Fiers, and A. J. van der Eb. 1974. Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40. Cold Spring Harbor Symp. Quant. Biol. 39:637-650.
24. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
25. Grand, R. J. A., M. L. Grant, and P. H. Gallimore. 1994. Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology 203:229-240.
26. Halbert, D. N., J. R. Cutt, and T. Shenk. 1985. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56:250-257.
27. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
28. Heise, C., A. Sampson-Johannes, A. Williams, F. McCormick, D. D. von Hoff, and D. H. Kirn. 1997. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3:639-644.
29. Ho, Y.-S., R. Galos, and J. Williams. 1982. Isolation of type 5 adenovirus mutants with a cold-sensitive host range phenotype: genetic evidence of an adenovirus transformation maintenance function. Virology 122:109-124.
30. Jones, N., and T. Shenk. 1979. Isolation of Ad5 host range deletion mutants defective in transformation of rat embryo cells. Cell 17:683-689.
31. Jones, N., and T. Shenk. 1978. Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13:181-186.
32. Kafotos, F. C., C. W. Jones, and A. Efstratiadis. 1979. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucleic Acids Res. 7:1541-1552.
33. Kao, C. C., P. R. Yew, and A. J. Berk. 1990. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55kD proteins. Virology 179:806-814.
34. Kute, T. E., H. B. Muss, D. Anderson, K. Crumb, B. Miller, D. Burns, and L. Dube. 1981. Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer. Cancer Res. 41:3524-3529.
35. Lehman, T. A., W. P. Bennett, R. A. Metcalf, J. A. Welsh, J. Ecker, R. V. Modali, S. Ullrich, J. W. Romano, E. Appella, J. R. Testa, B. I. Gerwin, and C. C. Harris. 1991. p53 mutations, ras mutations, and p53-heat shock protein complexes in human lung carcinoma cell lines. Cancer Res. 51:4090-4096.
36. Leppard, K. N., and T. Shenk. 1989.The adenovirus E1B-55 kD protein influences mRNA transport via an intranuclear effect on RNA metabolism. EMBO J. 8:2329-2336.
37. Lin, J., X. Wu, J. Chen, A. Chang, and A. J. Levine. 1994. Functions of p53 protein in growth regulation and tumor suppression. Cold Spring Harbor Symp. Quant. Biol. 59:215-223.
38. Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
39. Masuda, H., C. Miller, H. P. Koeffler, H. Battifora, and M. J. Cline. 1987. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. USA 84:7716-7719.
40. McDivitt, R. W., K. R. Stone, R. B. Craig, J. O. Palmer, J. S. Meyer, and W. C. Bauer. 1986. A proposed classification of breast cancer based on kinetic information. Cancer 57:269-276.
41. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
42. Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. D'Amico, S. Bodner, H. K. Oie, R. I. Linnoila, J. L. Mulshine, and J. D. Minna. 1992. p53 gene mutations in non-small-cell lung cancer lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
43. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
44. Moore, M., N. Horikoshi, and T. Shenk. 1996. Oncogenic potential of the adenovirus E4orf6 protein. Proc. Natl. Acad. Sci. USA 93:11295-11301.
45. Moore, M., J. Schaack, S. B. Baim, R. I. Morimoto, and T. Shenk. 1987. Induced heat shock mRNAs escape the nucleocytoplasmic transport block in adenovirus-infected HeLa cells. Mol. Cell. Biol. 7:4505-4512.
46. Nevels, M., S. Rubenwolf, T. Spruss, H. Wolf, and T. Dobner. 1997. The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc. Natl. Acad. Sci. USA 94:1206-1211.
47. Ornelles, D. A., and T. Shenk. 1991. Localization of the adenovirus early region 1B 55-kilodalton protein during lytic infection: association with nuclear viral inclusions requires the early region 4 34-kilodalton protein. J. Virol. 65:424-439.
48. Pilder, S., J. Logan, and T. Shenk. 1984. Deletion of the gene encoding the adenovirus 5 early region 1B 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA. J. Virol. 52:664-671.
49. Pilder, S., M. Moore, J. Logan, and T. Shenk. 1986. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6:470-476.
50. Querido, E., R. C. Marcellus, A. Lai, R. Charbonneau, J. G. Teodoro, G. Ketner, and P. E. Branton. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71: 3788-3798.
51. Quinlan, M. P. 1994. Enhanced proliferation, growth factor induction and immortilization by adenovirus E1A 12S in the absence of E1B. Oncogene 9:2639-2647.
52. Rao, L., M. Debbas, D. Sabbatini, D. Hockenberry, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742-7746.
53. Reich, N. C., P. Sarnow, E. Duprey, and A. J. Levine. 1983. Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology 128:480-484.
54. Ridgway, P., A. R. Hall, C. J. Myers, and A. W. Braithwaite. 1997. p53/E1b58kDa complex regulates adenovirus replication. Virology 237:404-413.
55. Rubenwolf, S., H. Scutt, M. Nevels, H. Wolf, and T. Dobner. 1997. Structural analysis of the adenovirus type 5 E1B 55-kilodalton-E4orf6 protein complex. J. Virol. 71:1115-1123
56. Ruley, H. E. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602-606.
57. Sarnow, P., Y. S. Ho, J. Williams, and A. J. Levine. 1982. Adenovirus E1b-58 kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54kd cellular protein in transformed cells. Cell 28:387-394.
58. Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523-5527.
59. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
60. Shepherd, S. E., J. A. Howe, J. S. Mymryk, and S. T. Bayley. 1993. Induction of the cell cycle in baby rat kidney cells by adenovirus type 5 E1A in the absence of E1B and a possible influence of p53. J. Virol. 67:2944-2949.
61. Steegenga, W. T., T. van Laar, A. Shvarts, C. Terleth, A. J. van der Eb, and A. G. Jochemsen. 1995. Distinct modulation of p53 activity in transcription and cell cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteins. Virology 212:543-554.
62. Stillman, B. 1986. Functions of the adenovirus E1B tumor antigens. Cancer Surv. 5:389-404.
63. Takahashi, T., M. M. Nau, I. Chiba, M. J. Birrer, R. K. Rosenberg, M. Vinocour, M. Levitt, H. Pass, A. F. Gazdar, and J. D. Minna. 1989. p53: a frequent target for genetic abnormalities in lung cancer. Science 246:491-494.
64. van den Elsen, P. J., A. Houweling, and A. J. van der Eb. 1983. Morphological transformation of human adenoviruses is determined to a large extent by gene products of region E1A. Virology 131:242-246.
65. van Engeland, M., L. J. W. Nieland, F. C. S. Ramaekers, B. Schutte, and C. P. M. Reutelingsperger. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9.
66. Werness, B. A., A. J. Levine, and P. M. Howely. 1990. Association of human papilloma virus types 16 and 18 E6 proteins p53. Science 248:76-79.
67. White, E. 1994. Function of the adenovirus E1B oncogene in infected and transformed cells. Semn. Virol. 5:341-348.
68. Williams, J., B. D. Karger, Y. S. Ho, C. L. Castiglia, T. Mann, and S. J. Flint. 1986. The adenovirus E1B 495R protein plays a role in regulating the transport and stability of the viral late messages. Cancer Cells 4:275-284.
69. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
70. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572-1583.
71. Yang, U.-C., W. Huang, and S. J. Flint. 1996. mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells. J. Virol. 70:4071-4080.
72. Yew, P. R., and A. J. Berk. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357:82-82.
73. Yew, R. P., X. Liu, and A. J. Berk. 1994. Adenovirus E1B oncoprotein tethers a trascriptional repression domain to p53. Genes Dev. 8:190-202.
74. Zambetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.
75. Zantema, A., J. A. M. Fransen, A. Davis-Oliver, F. C. S. Ramaekers, G. P. Vooijs, B. DeLeys, and A. J. van der Eb. 1985. Localization of the E1B proteins of adenovirus type 5 in transformed cells as revealed by interaction with monoclonal antibodies. Virology 142:44-58.
76. Zantema, A., P. I. Schrier, A. Davis-Oliver, T. van Laar, R. T. M. J. Vaessen, and A. J. van der Eb. 1985. Adenovirus serotype determines association and localization of the large E1B tumor antigen and cellular tumor antigen p53 in transformed cells. Mo. Cell. Biol. 5:3084-3091.
77. Zhang, J.F., C. Hu, Y. Geng, J. Selm, S. B. Klien, A. Orazi, and M. W. Taylor. 1996. Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy. Proc. Natl. Acad. Sci. USA 93:4513-4518.